Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma

Despite the high probability of glaucoma-related blindness, its cause is not fully understood and there is no efficient therapeutic strategy for neuroprotection. Vascular factors have been suggested to play an important role in glaucoma development and progression. Previously, we have proven the neu...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Patkó Evelin Viktória
Szabó Edina
Váczy Alexandra
Molitor Dorottya
Tari Eniko
Li Lina
Csutak Adrienne
Tóth Gábor
Reglődi Dóra
Atlasz Tamás
Dokumentumtípus: Cikk
Megjelent: 2023
Sorozat:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 No. 17
Tárgyszavak:
doi:10.3390/ijms241713256

mtmt:34117220
Online Access:http://publicatio.bibl.u-szeged.hu/29893
Leíró adatok
Tartalmi kivonat:Despite the high probability of glaucoma-related blindness, its cause is not fully understood and there is no efficient therapeutic strategy for neuroprotection. Vascular factors have been suggested to play an important role in glaucoma development and progression. Previously, we have proven the neuroprotective effects of pituitary adenylate-cyclase-activating polypeptide (PACAP) eye drops in an inducible, microbeads model in rats that is able to reproduce many clinically relevant features of human glaucoma. In the present study, we examined the potential protective effects of PACAP1-38 on the retinal vasculature and the molecular changes in hypoxia. Ocular hypertension was induced by injection of microbeads into the anterior chamber, while control rats received PBS. PACAP dissolved in vehicle (1 µg/drop) or vehicle treatment was started one day after the injections for four weeks three times a day. Retinal degeneration was assessed with optical coherence tomography (OCT), and vascular and molecular changes were assessed by immunofluorescence labeling. HIF1-α and VEGF-A protein levels were measured by Western blot. OCT images proved severe retinal degeneration in the glaucomatous group, while PACAP1-38 eye drops had a retinoprotective effect. Vascular parameters were deteriorated and molecular analysis suggested hypoxic conditions in glaucoma. PACAP treatment exerted a positive effect against these alterations. In summary, PACAP could prevent the severe damage to the retina and its vasculature induced by ocular hypertension in a microbeads model.
Terjedelem/Fizikai jellemzők:14
ISSN:1661-6596